Didier Meulien, MD
- 2Articles
- 6.1KReads1
- 2007–2009Active
- 14Collaborators
- 45Citations2
About
Didier Meulien, MD, has published research focusing on metabolic disorders and schizophrenia/schizoaffective disorders. Contributions include studies on glucose metabolism changes in schizophrenia patients treated with antipsychotics such as olanzapine, quetiapine, and risperidone, as well as investigations into the efficacy and tolerability of extended-release quetiapine fumarate in acute schizophrenia. Meulien's work appeared between 2007 and 2009 in Psychiatrist.com publications. Frequent collaborators include Martin Brecher, Efren B. Reyes, Frank Miller, Henrik M. Andersson, and Jan W. Eriksson.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
